LIGAND PHARMACEUTICALS INCORPORATED Available-for-sale Securities, Gross Unrealized Gain
LIGAND PHARMACEUTICALS INCORPORATED (LGND) reported Available-for-sale Securities, Gross Unrealized Gain of $4.95 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-23.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedGains · last filed 2015-02-23
- LIGAND PHARMACEUTICALS INCORPORATED available-for-sale securities, gross unrealized gain for the quarter ending 2013-12-31 was $713.00K.
- LIGAND PHARMACEUTICALS INCORPORATED available-for-sale securities, gross unrealized gain for the quarter ending 2013-09-30 was $806.00K.
- LIGAND PHARMACEUTICALS INCORPORATED available-for-sale securities, gross unrealized gain for fiscal 2014 was $4.95M, a 70.01% increase from fiscal 2013.
- LIGAND PHARMACEUTICALS INCORPORATED available-for-sale securities, gross unrealized gain for fiscal 2013 was $2.91M.
| Period end | Available-for-sale Securities, Gross Unrealized Gain 3 month | Available-for-sale Securities, Gross Unrealized Gain 6 month | Available-for-sale Securities, Gross Unrealized Gain 9 month | Available-for-sale Securities, Gross Unrealized Gain 12 month | Available-for-sale Securities, Gross Unrealized Gain 12 month as first filed |
|---|---|---|---|---|---|
| 2014-12-31 | $4.95M 10-K · filed 2015-02-23 | $2.91M 10-K · filed 2014-12-01 | |||
| 2013-12-31 | $713.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $1.52M derived: sum of 2 quarters · filed 2015-02-23 | $2.91M 10-K · filed 2015-02-23 | ||
| 2013-09-30 | $806.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $2.20M 10-Q · filed 2013-11-08 | |||
| 2013-06-30 | $1.40M 10-Q · filed 2013-08-01 |